HYPERTENSION PHENOTYPES AND KIDNEY INJURY IN YOUNG ADULTS: AN INTERNAL MEDICINE NEPHROLOGY INTERFACE
Main Article Content
Keywords
Hypertension phenotypes, systolic diastolic hypertension, isolated diastolic hypertension, isolated systolic hypertension, kidney injury, microalbuminuria, eGFR, young adults, internal medicine, and nephrology.
Abstract
Background: Hypertension in young adults is increasingly recognized as a precursor of chronic kidney disease, but its impact may vary depending on blood pressure phenotype.
Objective: To determine the distribution of hypertension phenotypes in young adults and to evaluate their association with early indicators of kidney injury.
Methods: A cross-sectional study was conducted at the Department of Nephrology, Mufti Mehmood Teaching Hospital, Dera Ismail Khan, Pakistan, from January to June 2024. Seventy-two young adults aged 18–35 years were enrolled. Demographic and clinical details were recorded, and participants were classified into normotension, isolated systolic hypertension (ISH), isolated diastolic hypertension (IDH), systolic–diastolic hypertension (SDH), masked hypertension, and white-coat hypertension. Renal function was assessed using serum creatinine, estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio (UACR). Kidney injury was defined as microalbuminuria (UACR ≥ 30 mg/g) or eGFR < 90 ml/min/1.73m².
Results: SDH was the most common phenotype (31.9%), followed by IDH (19.4%) and ISH (16.7%). SDH was strongly associated with kidney injury, with 52.2% of affected individuals showing either microalbuminuria or reduced eGFR (p = 0.004). Normotensive participants had preserved renal function, while masked and white-coat hypertension showed intermediate risk.
Conclusion: Hypertension phenotypes in young adults differ in their renal implications, with SDH carrying the highest risk for early kidney injury. Phenotype-specific risk stratification and timely renal monitoring may help reduce the long-term burden of chronic kidney disease in this population.
References
2. Rodrigues, C.E. and Z.H.J.N. Endre, Definitions, phenotypes, and subphenotypes in acute kidney injury—Moving towards precision medicine. 2023. 28(2): p. 83-96.
3. Goldstein, S.L., et al., Consensus-based recommendations on priority activities to address acute kidney injury in children: a modified Delphi consensus statement. 2022. 5(9): p. e2229442-e2229442.
4. Zoccali, C., et al., Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. 2023. 119(11): p. 2017-2032.
5. Alexander, M.R., et al., A single nucleotide polymorphism in SH2B3/LNK promotes hypertension development and renal damage. 2022. 131(9): p. 731-747.
6. Audemard-Verger, A., et al., Impact of aging on phenotype and prognosis in IgA vasculitis. 2021. 60(9): p. 4245-4251.
7. Vaclavik, J., et al., BILATERAL RENAL ARTERY EMBOLIZATION IN END-STAGE RENAL DISEASE AND RESISTANT HYPERTENSION. 2021. 39: p. e294-e295.
8. Sardu, C., et al., Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. 2020. 9(5): p. 1417.
9. Kermond, R., A. Mallett, and H.J.P.N. McCarthy, A clinical approach to tubulopathies in children and young adults. 2023. 38(3): p. 651-662.
10. Bureau, C., et al., Nephrosclerosis in young patients with malignant hypertension. 2023. 38(8): p. 1848-1856.
11. Gumz, M.L., et al., Toward precision medicine: circadian rhythm of blood pressure and chronotherapy for hypertension-2021 NHLBI workshop report. 2023. 80(3): p. 503-522.
12. Dennis, M.R., P.W. Pires, and C.T.J.J.o.v.r. Banek, Vascular dysfunction in polycystic kidney disease: a mini-review. 2023. 60(3): p. 125-136.
13. Armaly, Z., S. Kinaneh, and K.J.J.o.c.m. Skorecki, Renal manifestations of Covid-19: physiology and pathophysiology. 2021. 10(6): p. 1216.
14. Tanriover, C., et al., Early aging and premature vascular aging in chronic kidney disease. 2023. 16(11): p. 1751-1765.
15. Wieërs, M.L., et al., Potassium and the kidney: a reciprocal relationship with clinical relevance. 2022. 37(10): p. 2245-2254.
16. Burballa, C., et al., Clinical and genetic characteristics of Dent's disease type 1 in Europe. 2023. 38(6): p. 1497-1507.
17. Brant, L.C.C., et al., The burden of resistant hypertension across the world. 2022. 24(3): p. 55-66.
18. Villalvazo, P., et al., Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved. 2021. 14(11): p. 2285-2294.
19. Serre, J., et al., Diagnostic Yield of Exome Sequencing in Early Onset Hypertensive Nephropathy in Adults: SA-PO545. 2022. 33(11S): p. 755.
20. Lonardo, A., et al., Nonalcoholic fatty liver disease and chronic kidney disease: epidemiology, pathogenesis, and clinical and research implications. 2022. 23(21): p. 13320.
21. Dupont, V., et al., Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway. 2022. 132(20).
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Kulsoom Ilyas
Specialist Nephrology, Ministry of Health UAE
Naema Liaqat
Specialist Nephrology, Emirates Health Services, UAE
Asmara Ali
Specialist Internal Medicine, Emirates Health Services, UAE
Shumaila Zaheer Naqvi
General Practitioner Medicine, Dubai Health Authority, UAE
Randa Khrais
Intern Medicine, Emirates Health Services, UAE
Behzad Kaleem Baloch
Assistant Professor Nephrology, Mufti Mehmood Teaching Hospital, Dera Ismail Khan, Pakistan